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ABSTRACT: Transmission dynamics of Toxoplasma gondii, a parasite of importance for wildlife and
human health, are enigmatic in the Arctic tundra, where free-ranging wild and domestic felid definitive
hosts are absent and rarely observed, respectively. Through a multiyear mark-recapture study (2011–
17), serosurveillance was conducted to investigate transmission of T. gondii in Arctic foxes (Vulpes
lagopus) in the Karrak Lake region, Nunavut, Canada. Sera from adult foxes and fox pups were tested
for antibodies to T. gondii by using serologic methods, including the indirect fluorescent antibody test,
direct agglutination test, and modified agglutination test. The overall seroprevalence was 39% in adults
and 17% in pups. Mature foxes were more likely to be exposed (seroconvert) than young foxes (less than
1 yr old), with the highest level of seroprevalence in midaged foxes (2–4 yr old). Pups in two different
litters were seropositive on emergence from the den, around 5 wk old, which could have been due to
passive transfer of maternal antibody or vertical transmission of T. gondii from mother to offspring. The
seropositive pups were born of seropositive mothers that were also seropositive the year before they
gave birth, suggesting that vertical transmission might not be limited to litters from mothers exposed to
T. gondii for the first time in pregnancy. All recaptured seropositive foxes remained seropositive on
subsequent captures, suggesting that antibodies persist or foxes are constantly reexposed or a
combination of both. The results of this study provided insights into how foxes were likely exposed to T.
gondii, the dynamics of antibody persistence and immune response, and how the parasite was
maintained in a terrestrial Arctic ecosystem in the absence of felid definitive hosts.
Key words: Arctic fox, IFAT, Karrak Lake, MAT, Toxoplasma, vertical transmission.
INTRODUCTION
Toxoplasma gondii is a protozoan infecting
a wide taxonomic range of birds and mammals
worldwide (Dubey 2010). In these warm-
blooded animals, it usually causes no symp-
toms but can cause neurologic, ocular, and
reproductive problems, especially in immuno-
compromised or pregnant hosts (Kim and
Weiss 2008). Toxoplasma gondii reproduces
sexually only within the intestines of felid
definitive hosts, but a wide range of vertebrate
intermediate hosts can be infected by inges-
tion of oocysts shed in feline feces (Dubey et
al. 1970). Intermediate hosts can also become
infected by ingestion of tissue cysts of T.
gondii from infected prey or vertically by
transmission through the placenta or by
ingestion of milk from an acutely infected
mother (Dubey 2009). Congenital infection
occurs in wild populations of mice and in
sheep and may be more common than
previously thought in free-ranging wild ani-
mals (Tenter et al. 2000). In captive foxes,
newborn pups with acute systemic toxoplas-
mosis born of experimentally infected Arctic
foxes (Vulpes lagopus) have high mortality
(Bjerkas 1990). Reports of infected vixens and
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death of neonates has been demonstrated in
farmed foxes (Smielewska-Los et al. 2000).
Little is known about the occurrence of
vertical transmission and dynamics of anti-
bodies to T. gondii in wild populations of
foxes, as long-term, mark-recapture studies
are rare.
Even though the current world population
of Arctic fox is stable at several 100,000
animals (Angerbjo¨rn and Tannerfeldt 2014),
some local populations are of conservation
concern due to the effects of environmental
change and competition with other carnivores,
such as red foxes (Vulpes vulpes) moving
north (Pamperin et al. 2006; Elmhagen et al.
2017). Mortality of Arctic foxes from acute
disseminated T. gondii has occurred in
Svalbard, Norway (Sørensen et al. 2005). In
that population, seroprevalence was 43% in
594 foxes tested, and prevalence was higher in
foxes less than 1 yr old, with seropositive foxes
as young as 6–9 mo old, suggesting that
vertical transmission could be an important
mode of transmission in Arctic foxes (Prestrud
et al. 2007), in addition to trophic interactions.
Since 2000, studies of Arctic foxes have
been conducted at Karrak Lake, in Nunavut,
Canada, focusing on foraging behavior and
population dynamics in relation to variation in
foods (Samelius et al. 2007; Samelius and
Alisauskas 2017). Starting in 2011, blood from
live-captured Arctic foxes was collected and
analyzed for T. gondii annually (Elmore et al.
2016). This ongoing project is an opportunity
to monitor disease transmission dynamics in a
natural population of Arctic foxes. The tissue
stages of T. gondii require invasive or
postmortem techniques for detection; alter-
natively, serology serves as a relatively nonin-
vasive indicator of exposure to T. gondii. No
study has investigated seroprevalence in both
mothers and pups newly emerged from their
dens. Pups emerge from the den after 3–4 wk
and are weaned at 6–7 wk (Audet et al. 2002).
In the rare occurrence of felid definitive
hosts for T. gondii in the tundra regions of the
Arctic, other transmission routes might occur,
including vertical transmission and ingestion
of tissue cysts in migratory wildlife via
carnivory. Previous work has demonstrated
that migratory birds are a potential source for
introduction of toxoplasmosis and that adult
Arctic foxes are likely infected through
carnivory (Elmore et al. 2014, 2015). In this
work, we examined blood samples from live-
captured adults and, for the first time to our
knowledge, juvenile Arctic foxes (pups), by
using serologic methods for detection of
antibody to T. gondii. This information
contributed to furthering an understanding
of immune responses and transmission of this
ubiquitous parasite in Arctic ecosystems.
MATERIALS AND METHODS
Study area
Each spring (May–June in 2011 to 2017), adult
Arctic foxes were captured at the Karrak Lake
goose colony (678140N, 1008150W), in the Queen
Maud Gulf Bird Sanctuary, Nunavut, Canada
(Fig. 1), as well as juvenile Arctic foxes (pups) in
June–July in 2014–16. Over one million Ross’s
Geese (Chen rossii) and Lesser Snow Geese
(Chen caerulescens) have nested annually at this
site, making it one of the largest goose colonies on
Earth (Alisauskas et al. 2012). Arctic foxes in this
region rely heavily on small mammals for food
(Samelius et al. 2007), including collared lem-
mings (Dicrostonyx groenlandicus), brown lem-
mings (Lemmus sibiricus), and northern red-
backed voles (Myodes rutilus). Other food sourc-
es, such as birds and eggs, are an important part of
their diet as well, especially when small mammals
are scarce (Samelius et al. 2007). Nevertheless,
lemming abundance remains the main factor
driving fluctuation of Arctic fox population and
reproduction, even when seasonally abundant
foods, such as geese, are available (Samelius et
al. 2011; Samelius and Alisauskas 2017).
Fox capture and blood sampling
Adult arctic foxes were captured by using box
traps, a one-door live animal cage trap (Havahart
model 1089, Woodstream Corporation, Lititz,
Pennsylvania, USA). Traps were baited with
sardines and wired open a few days prior to
capture to accustom foxes to the traps. The traps
were placed at locations with signs of fox activity
(e.g., den sites, elevated knolls, and large rocks) in
an area (5314 km) of the central part of the goose
colony. Once captured, 15 mg of tiletamine-
zolazepam (Telazolt, Zoetis Inc., Kalamazoo,
Michigan, USA) was injected intramuscularly into
the upper part of the back leg following Samelius
et al. (2003). Foxes were individually marked with
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permanent plastic ear tags (133.5 cm in size;
Dalton ID Systems Ltd., Oxfordshire, UK),
weighed, and sexed. Blood samples (about 2
mL) were collected from the cephalic vein,
centrifuged at 6,000 3 G for 20 min, and sera
stored at20 C at the field camp for about 2 mo.
Adult foxes were categorized into three different
age classes on the basis of tooth wear and previous
capture history following Elmore et al. (2016):
young (1 yr old), mid aged (2–4 yr old), and
older (5 yr old). Pups were handled as per adult
foxes, except chemical immobilization was not
necessary, and blood was collected from the
jugular versus cephalic vein.
These procedures were approved by the
University of Saskatchewan Animal Care Com-
mittee for blood collection (protocol 20100159)
and live trapping (19990029) and followed the
Guidelines of the Canadian Council on Animal
Care. We also held wildlife research permits from
the Nunavut Department of Environment (2011-
018, 2012-022, 2013-017, 2014-029, 2015-019,




Each serum sample was tested by using two
different serologic analyses. Samples from 2011 to
2013 were tested with a commercially available
direct agglutination test (DAT) at 1:40 dilution
according to the manufacturer’s instructions (Tox-
oScreen-DA, BioMe´rieux, Marcy l’Etoile, France).
Samples from 2014 to 2017 were tested by using a
commercially available modified agglutination test
(MAT) at three dilutions (1:25; 1:50; and 1:100; Al-
Adhami et al. 2016) according to the manufacturer
instructions (New Life Diagnostic LLC, Carlsbad,
California, USA), with 1:25 as a cutoff for
seropositivity. Questionable results consisting of
mild agglutination covering less than half of the test
well were considered negative.
In all years, an indirect fluorescent antibody
test (IFAT) was performed on diluted fox serum
(1:50) following the manufacturer’s instructions
(VMRD, Inc., Pullman, Washington, USA). Anti-
FIGURE 1. Location of the Karrak Lake Ross’s Goose (Chen rossii) and Lesser Snow Goose (Chen
caerulescens) colony in Nunavut, Canada, at which the transmission of Toxoplasma gondii in Arctic fox (Vulpes
lagopus) was studied in a long-term (2011–17) mark-recapture serology design. The black rectangle represents
the study area in the colony, the dots indicate Arctic fox dens, and the square shows the location of the field
camp.
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canine immunoglobulin G (IgG) antibodies con-
jugated to fluorescein isothiocyanate (rabbit
origin) were applied on slides. Slides were viewed
under an Olympus BX51TF fluorescence micro-
scope (Olympus, Tokyo, Japan), with an Olympus
DP72 camera (Olympus) at 403 objective. A
complete staining around the tachyzoites was
considered positive for T. gondii antibodies.
Tachyzoites with little, discontinuous, or no
staining were recorded as negative.
A sample was considered positive if both the
agglutination and IFAT assays gave positive
results. Both tests were read by the same person
for 2011–13, as well as for 2014–17, blinded
between assays.
Data analysis
Statistical analyses (prevalence, mean, SE, and
95% confidence interval [CI]) were performed by
using R v3.4.3 (R Development Core Team 2017).
The agreements between tests were determined
by the kappa (j) coefficient, where j¼1.00
represented a perfect correlation.
RESULTS
A total of 55 individual adult foxes were
captured between 2011 and 2017, with 27
recaptures (Table 1). The annual seropreva-
lences for T. gondii in adult Arctic foxes,
including recaptures, were determined (Table
2). Mean seroprevalence in adults was 39%
for all years of the study (SE¼7, 95% CI¼28–
50).
In the 41 pups captured in 2014–16, the
mean seroprevalence was 17% (SE¼16, 95%
CI¼7–32), and annual seroprevalences were
calculated (Table 3). For MAT, positive
samples for adults and juveniles were positive
at all three dilutions. The j coefficient was
0.76 for DAT and IFAT, and 0.97 for MAT
and IFAT.
Four recaptured foxes seroconverted (i.e.,
changed from seronegative to seropositive)
over the course of the study (Table 1). By
estimating the age of adults on the last
capture, one was older, two were mid aged,
and one was younger at the time of serocon-
version. All recaptured seropositive foxes
remained seropositive on subsequent cap-
tures; three foxes remained seropositive for
at least 3 to 4 yr (Table 1). The age of
seropositive pups ranged from 5–8 wk, all
TABLE 1. Long-term trends for the presence (þ) or absence () of antibodies to Toxoplasma gondii in adult
Arctic foxes (Vulpes lagopus) recaptured at Karrak Lake, Nunavut, Canada, for 2011–17 by using the modified
agglutination test and indirect fluorescent antibody test.a
Fox
ID Sex
Ageb Presence of antibodies by yearc
First capture Last capture 2011 2012 2013 2014 2015 2016 2017
OYPO M Mid aged Older      NA NA
PPYO M Mid aged Older   NA þ þ NA NA
OOPP F Mid aged Older  NA NA  NA NA NA
OOGG M Older Older NA þ þ NA NA NA NA
PYYO F Young Mid aged NA  NA þ þ NA NA
YPPY F Young Mid aged NA þ þ þ þ NA NA
POPP F Young Mid aged NA  þ þ NA NA NA
PYOY F Young Mid aged NA NA þ þ þ NA NA
OYYY F Older Older NA NA  þ þ NA NA
PPYY M Young Mid aged NA NA   NA NA NA
YYOO M Mid aged Mid aged NA NA þ þ NA NA NA
YYGO F Young Mid aged NA NA  NA  NA NA
PYYY M Mid aged Older NA NA þ NA þ þ NA
GOPY F Mid aged Mid aged NA NA NA NA þ þ NA
GGPP F Mid aged Mid aged NA NA NA NA NA  
a Foxes that seroconverted are identified in boldface.
b Young (1 yr), mid aged (2–4 yr), and older (5 yr).
c NA ¼ not taken.
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were still nursing when captured, and all had
seropositive mothers (PYOY and PYYO) who
were seropositive in previous years as well
(Tables 1, 4). Three seropositive females
(PYOY, POPP, and OYYY) had only seroneg-
ative pups (Table 4) at 5–9 wk old.
DISCUSSION
We demonstrated, for the first time, the
presence of antibodies to T. gondii in free-
ranging Arctic fox pups as young as 5 wk old,
born of seropositive mothers. This was con-
sistent with either passive transfer of maternal
antibodies or vertical transmission of T. gondii
from mother to young. Maternal IgG antibod-
ies may passively transfer in utero to the fetus
or through the colostrum and milk (Reming-
ton et al. 2004). Maternal antibodies represent
an important part of circulating IgG in pups.
The production of IgG derived from maternal
antibodies usually stops abruptly as soon as
weaning takes place, at around 6–7 wk of age
for fox pups (Van de Perre 2003). Passive
transfer may account for the single positive
pup (tested at 5 wk old) of seven pups (tested
at 6–9 wk old) from a seropositive female in
2014. However, antibodies were not detected
in pups in the same age range (5–9 wk old) in
three other litters from seropositive mothers.
For the other seropositive pups (estimated
age 6–8 wk old), the entire litter demonstrated
IgG antibodies against T. gondii, with the
older pups having titers as high as the younger
pups. Transfer of maternal antibodies could
be a possibility, but we would expect lower
detection of IgG in the older pups as the titer
of IgG drops with increasing age (Omata et al.
1994). In dogs, passively transferred maternal
IgG antibodies are estimated to reach their
lowest point between 4 wk old and 8 wk old,
depending on the intake of colostrum (Fels-
burg 2002). Our results provided new infor-
mation about the duration of maternal
antibody in free-ranging Arctic fox popula-
tions or suggested that vertical transmission of
T. gondii might have occurred in Arctic
carnivores. Vertical transmission could be
either transplacental (Bresciani et al. 2009)
or transmammary (Powell et al. 2001).
Interestingly, both litters with seropositive
pups were from mothers that had been
seropositive the year previously. If our find-
ings did represent vertical transmission of the
parasite, this suggested that transmission of T.
gondii may occur in multiple litters. Similar
findings have also been reported in deer mice
(Peromyscus maniculatus) with T. gondii
(Rejmanek et al. 2010) and in dogs with the
closely related parasite Neospora caninum
(Dubey et al. 1990). Previously, it was
supposed that fetuses became infected with
T. gondii only when the mammalian female
was infected for the first time during preg-
nancy and lactation, as assumed for humans
(Moncada and Montoya 2012). Finally, trans-
mission of tachyzoites to females by males
through semen also remains a possible route
TABLE 2. Serologic prevalence of Toxoplasma gondii
in adult Arctic foxes (Vulpes lagopus), including
recaptured foxes at Karrak Lake, Nunavut, Canada,
for 2011–17 by using the modified agglutination test








2011 10 1 (10) 0–45
2012 20 5 (25) 9–49
2013 15 8 (53) 27–79
2014 14 8 (57) 29–82
2015 14 7 (50) 23–77
2016 5 2 (40) 5–85
2017 4 1 (25) 0–81
Total 82 32 (39) 28–50
TABLE 3. Serologic prevalence of Toxoplasma gondii
in Arctic fox (Vulpes lagopus) pups at Karrak Lake,
Nunavut, Canada, for 2014–16 by using the modified









2014 18 1 (6) 0–27
2015 12 6 (50) 21–79
2016 11 0 (0) 0–28
Total 41 7 (17) 7–32
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for infection of female foxes and their pups
(Arantes et al. 2009). However, we were
unable to explore this hypothesis, as only
one male mated to a seronegative female was
seropositive (all of their pups were seroneg-
ative).
A significant limitation of the current study
was the reliance on noninvasive sampling and
serologic assays. Serology is often the only
tool available for surveillance in wildlife, but
results must be carefully interpreted, espe-
cially when tests optimized for domestic
species or humans are used in wildlife.
Agglutination (DAT or MAT) and IFAT
methods were used due to their long history
in wildlife surveillance for exposure to T.
gondii, the availability of mammalian or
canid-specific reagents, and their demon-
strated high detection probability when
compared with other test methods in Arctic
fox (Elmore et al. 2016). Test results
correlated well in this study, with a j
coefficient of 0.76 for DAT and IFAT and
0.97 for MAT and IFAT, showing good and
very good test agreement, respectively. Fi-
nally, we were conservative in our interpre-
tation, requiring that animals be positive for
both an agglutination assay and the IFAT to
be considered positive.
Live trapping, tagging, and monitoring for
antibodies to T. gondii in adult Arctic foxes at
Karrak Lake demonstrated that the overall
seroprevalence was relatively stable over time
(Table 2), considering the 95% CI and low
sample sizes. A stable seroprevalence in the
Karrak Lake fox population would indicate a
constant infection pressure from their envi-
ronment (Opsteegh et al. 2011), meaning that
foxes are routinely exposed to T. gondii,
whether it is by trophic or vertical transmis-
TABLE 4. Serologic prevalence of Toxoplasma gondii in adult Arctic foxes (Vulpes lagopus) and their litters at





Litter sizeSex Resultsc No. positive (age) No. negative (age)
2014 PYOY Female þ 1 (5 wk) 6 (5–8 wk) 7
OYPO Male  — — —
POPP Female þ NA 6 (7–9 wk) 7
PPYY Male  — — —
OYYY Female þ NA 5 (6–7 wk) 9
PPYO Male þ — — —
2015 PYOY Female þ NA 4 (7 wk) 7
OYPO Male  — — —
PPPP Female  NA 2 (8 wk) 5
Unknown Male NA — — —
PYYO Female þ 6 (6–8 wk) NA 11
PYYY Male þ — — —
YYYP Female NA NA NA NA
YYYY Male  — — —
2016 GGOP Female  NA 5 (5–8 wk) 6
PYYY Male þ — — —
GPGP Female  NA 4 (5–8 wk) 5
Unknown Male NA — — —
Unknown Female NA NA 2 (7 wk) 3
Unknown Male NA — — —
a Samples from adult foxes and pups were tested by the modified agglutination test and indirect fluorescent antibody test. NA ¼ not
applicable.
b — ¼ breeding male paired with the female above it.
c þ¼ positive;¼ negative.
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sion or both. In the long term, changes in
serostatus of recaptured foxes provide insight
into timing of exposure and antibody persis-
tence in naturally infected animals. Four foxes
seroconverted over the course of the study,
including three mature foxes and one young
fox. Mid aged and older foxes are more likely
to be exposed to T. gondii via foodborne
routes than young foxes. Three animals
remained seropositive for at least 3 to 4 yr,
suggesting antibody persistence or reexposure
or a combination of both. Antibodies against
Toxoplasma are usually thought to persist for a
lifetime in the host, probably due to constant
antigenic stimulation from persistent tissue
cysts (Remington and Krahenbuhl 1982).
However, a recent study highlights that
lifelong persistence of tissue cysts and pro-
tective immunity to T. gondii has yet to be
demonstrated (Rougier et al. 2017). Although
our sample size of recaptured animals is not
sufficient to understand fully the dynamics of
antibody persistence, ongoing study of the
prevalence of T. gondii antibodies in this fox
population will provide a better idea of the
dynamics of disease transmission and persis-
tence of antibodies and whether chronic T.
gondii infection may result in negative im-
pacts on foxes, such as reduced reproductive
success and survival.
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